Abstract
Neurotensin-polyplex
nanoparticles
provide
efficient
gene
transfection
of
nigral
dopaminergic
neurons
when
intracerebrally
injected
in
preclinical
trials
Parkinson’s
disease
because
they
do
not
cross
the
blood–brain
barrier
(BBB).
Therefore,
this
study
aimed
to
open
BBB
with
focused
ultrasound
(FUS)
on
substantia
nigra
attain
systemic
and
intranasal
transfections
evaluate
its
detrimental
effect
rats.
Systemically
Evans
Blue
showed
that
a
two-pulse
FUS
opened
BBB.
Accordingly,
35
μL
neurotensin-polyplex
encompassing
green
fluorescent
protein
plasmid
(79.6
nm
mean
size
+
1.3
mV
Zeta-potential)
caused
expression
tyrosine
hydroxylase(+)
cells
(dopaminergic
neurons)
both
substantiae
nigrae
upon
delivery
via
internal
carotid
artery,
retro-orbital
venous
sinus,
or
nasal
mucosa
30
min
after
FUS.
The
intracarotid
yielded
highest
transgene
expression,
followed
by
administration.
However,
neuroinflammation
displayed
infiltrated
lymphocytes
(positive
cluster
differentiation
45),
activated
microglia
ionized
calcium-binding
adaptor
molecule
1),
neurotoxic
A1
astrocytes
glial
fibrillary
acidic
complement
component
3),
neurotrophic
A2
S100
A10),
ended
15
days
Dopaminergic
axonal
projections
decreased
but
recuperated
basal
values
day
transfection,
correlating
decrease
recovery
locomotor
behavior.
In
conclusion,
transient
reversible
neuronal
affection
allowed
nigrae.
could
advance
nanotechnology
clinical
for
disease.
Journal of Clinical Medicine,
Год журнала:
2025,
Номер
14(2), С. 386 - 386
Опубликована: Янв. 9, 2025
The
blood-brain
barrier
(BBB)
is
a
crucial
structure
that
maintains
brain
homeostasis
by
regulating
the
entry
of
molecules
and
cells
from
bloodstream
into
central
nervous
system
(CNS).
Neurodegenerative
diseases
such
as
Alzheimer's
Parkinson's
disease,
well
ischemic
stroke,
compromise
integrity
BBB.
This
leads
to
increased
permeability
infiltration
harmful
substances,
thereby
accelerating
neurodegeneration.
In
this
review,
we
explore
mechanisms
underlying
BBB
disruption,
including
oxidative
stress,
neuroinflammation,
vascular
dysfunction,
loss
tight
junction
integrity,
in
patients
with
neurodegenerative
diseases.
We
discuss
how
breakdown
contributes
neurotoxicity,
abnormal
accumulation
pathological
proteins,
all
which
exacerbate
neuronal
damage
facilitate
disease
progression.
Furthermore,
potential
therapeutic
strategies
aimed
at
preserving
or
restoring
function,
anti-inflammatory
treatments,
antioxidant
therapies,
approaches
enhance
integrity.
Given
role
neurodegeneration,
maintaining
its
represents
promising
approach
slow
prevent
progression
Journal of Neurochemistry,
Год журнала:
2025,
Номер
169(2)
Опубликована: Фев. 1, 2025
Consumption
of
alcoholic
beverages
during
pregnancy
is
directly
related
to
the
establishment
fetal
alcohol
spectrum
disorders
(FASD),
which
includes
craniofacial
changes,
body
growth
restriction,
and
neurodevelopment
impairments.
Proper
functioning
central
nervous
system
(CNS)
depends
on
blood-brain
barrier
(BBB)
development,
formed
by
interactions
vascular
endothelial
cells,
pericytes,
astrocytes,
basal
lamina.
Gestational
exposure
ethanol
has
been
demonstrated
impair
CNS
development;
however,
little
known
about
modulation
blood
circulating
factors
impacts
human
developing
BBB.
Here
we
investigated
prevalence
consumption
found
that
27%
pregnant
women
reported
consumption,
mainly
in
first
trimester.
Control
alcohol-exposed
newborns
showed
no
differences
weight,
length,
appearance,
pulse,
grimace,
activity,
respiration
(APGAR)
score
at
birth.
In
vitro,
cultivated
brain
microcapillary
cells
(HBMEC)
treated
with
umbilical
cord
serum
(UCBS)
from
control
(S-Control)
or
ethanol-exposed
ones
(S-Ethanol).
S-Ethanol
treatment
induced
68%
38%
decreases
protein
levels
ZO-1
(tight
junction)
GLUT-1
(glucose
transporter
type-1),
respectively,
increased
monolayer
permeability,
migratory
potential
impairment,
changes
angiogenesis-related
secreted
proteins
profile,
compared
S-Control
treatments.
UCBS
proteomics
revealed
a
total
392
proteins,
10
exclusively
S-Ethanol,
mostly
innate
adaptive
immunity
tissue
injury
response.
These
results
suggest
gestational
contributes
altered
profiles
triggering
BBB
endothelial.
Acta Biomaterialia,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
Therapeutic
biomacromolecules
such
as
genetic
material,
antibodies,
growth
factors
and
enzymes
represent
a
novel
therapeutic
alternative
for
neurological
diseases
disorders.
In
comparison
to
traditional
therapeutics,
which
are
mainly
based
on
small
molecular
weight
drugs
that
address
the
symptoms
of
these
disorders,
can
reduce
undesired
side
effects
target
specific
pathological
pathways,
thus
paving
way
towards
personalized
medicine.
However,
undergo
degradation/denaturation
processes
in
physiological
environment
show
poor
capacity
cross
blood-brain
barrier
(BBB).
Consequently,
they
rarely
reach
central
nervous
system
(CNS)
their
active
form.
Herein,
we
critically
overview
several
polymeric
nanocarriers
protect
deliver
across
BBB.
Polymeric
first
categorized
architecture
(biodegradable
solid
nanoparticles,
nanogels,
dendrimers,
self-assembled
nanoparticles),
ultimately
determines
physico-chemical
properties
function.
The
available
formulations
then
thoroughly
analyzed,
placing
particular
attention
those
strategies
ensure
stability
during
encapsulation
process
promote
passage
BBB
by
controlling
physical
(e.g.,
mechanical
properties,
size,
surface
charge)
chemical
functional
groups,
targeting
motifs)
properties.
Accordingly,
this
review
gives
unique
perspective
delivery
BBB,
representing
concise,
complete
easy-to-follow
guide,
will
be
high
interest
chemists,
material
scientists,
pharmacologists
biologists.
Besides,
it
also
provides
critical
about
limited
clinical
translation
systems.
STATEMENT
OF
SIGNIFICANCE:
increasing
incidence
disorders
is
major
health
concern.
use
has
been
placed
spotlight
many
investigations.
reaching
concentration
levels
restricted
and,
thus,
represents
main
challenge
when
developing
efficient
therapies.
provide
discussion
into
system,
highlighting
potential
future
directions
overcome
current
challenges.
Journal of Controlled Release,
Год журнала:
2025,
Номер
381, С. 113595 - 113595
Опубликована: Март 6, 2025
In
receptor-mediated
transcytosis
(RMT)
of
large
therapeutics
across
the
blood-brain
barrier
(BBB),
construct
-
a
macromolecule
or
larger
carrier
with
therapeutic
payload
binds
protein
on
brain
capillary
endothelial
cells
(BCEC),
internalization
and
release
into
parenchyma.
The
construct's
into,
trafficking
from,
but
also
possible
entrapment
within
BCEC
are
affected
by
its
engineered
properties
whose
optimization
has
helped
derive
insights
transport
mechanisms
at
BCEC.
Furthermore,
advances
in
multi-omics,
as
well
large-scale
screening
directed
evolution
campaigns
have
identify
new
targets
for
RMT
this
perspective,
I
raise
reflect
some
fundamental
questions
one
can
arrive
comparing
BBB-targeted
constructs
different
target
proteins.
These
concern
underlying,
transcytosis-promoting
factors
that
constructs'
appears
to
converge
on,
precise
role
proteins
RMT,
through
which
these
may
mediate
trafficking,
tentative
criteria
selection
Based
considerations
propose
several
scenarios
strategies
interfere
more
efficient
internalization,
endosomal
network
toward
abluminal
membrane,
from
BCEC,
both
smaller
macromolecules
carriers.
European Journal of Neuroscience,
Год журнала:
2025,
Номер
61(8)
Опубликована: Апрель 1, 2025
ABSTRACT
Extracellular
vesicles
(EVs)
have
emerged
as
pivotal
mediators
in
neurological
diseases,
showcasing
multifaceted
potential
roles
ranging
from
pathogenesis
to
diagnosis.
These
nano‐sized
membranous
structures,
released
by
various
cell
types
including
neurons,
astrocytes,
and
microglia,
encapsulate
a
diverse
cargo
of
proteins,
lipids,
RNA
species,
even
DNA
fragments.
In
neuropathology,
EVs
contribute
significantly
intercellular
communication
within
the
central
nervous
system
(CNS),
influencing
physiological
or
pathological
cascades.
Through
transfer
bioactive
molecules,
modulate
neuroinflammation,
neuronal
survival,
synaptic
plasticity,
propagation
protein
aggregates
characteristic
neurodegenerative
disorders.
Moreover,
their
presence
biofluids
such
cerebrospinal
fluid
(CSF),
blood,
urine
reflects
pathophysiological
state
CNS,
offering
window
into
diagnosis,
monitoring
treatment
diseases.
Recent
advancements
EV
isolation
techniques,
coupled
with
high‐throughput
omics
technologies,
facilitated
profiling
cargo,
enabling
identification
disease‐specific
biomarkers
high
sensitivity
specificity.
This
review
explores
intricate
highlighting
involvement
Alzheimer's
disease,
Parkinson's
multiple
sclerosis,
other
Furthermore,
it
delves
diagnostic
EVs,
discussing
current
challenges
prospects
harnessing
EV‐derived
for
precision
medicine
neurology.
Ultimately,
understanding
biology
contexts
promises
transformative
insights
disease
mechanisms
therapeutic
strategies,
paving
way
innovative
tools
targeted
interventions
clinical
practice.
NMR in Biomedicine,
Год журнала:
2024,
Номер
37(9), С. e5149 - e5149
Опубликована: Сен. 1, 2024
The
central
nervous
system
(CNS)
lacks
traditionally
defined
lymphatic
vasculature.
However,
CNS
tissues
and
barriers
compartmentalize
the
brain,
spinal
cord,
adjacent
spaces,
facilitating
transmittal
of
fluids,
metabolic
wastes,
immune
cells,
vital
signals,
while
more
conventional
pathways
in
meninges,
cervicofacial
paraspinal
regions
transmit
efflux
fluid
molecules
to
peripheral
lymph
nodes.
Thus,
a
unique
highly
organized
circulation
network
encompassing
intraparenchymal,
subarachnoid,
dural,
extradural
segments
functions
unison
maintain
homeostasis.
Pathways
involved
this
have
been
under
investigation
for
centuries
continue
be
source
considerable
interest
debate.
Modern
imaging
microscopy
technologies
led
important
breakthroughs
pertaining
various
elements
circuitry
exchange
over
past
decade,
thus
enhancing
knowledge
on
mechanisms
mammalian
maintenance
disease.
Yet,
better
understand
precise
anatomical
routes,
physiology
clinical
significance
these
pathways,
potential
therapeutic
targets
humans,
conduits,
flow-regulating
factors,
tissue
effects
must
analyzed
systematically
global
manner
persons
across
age,
demographical
disease
states.
Here,
we
illustrate
system-wide
nature
intermixing
networks,
summarize
historical
studies,
discuss
physiological
similarities
differences
that
are
relevant
translation
evidence
from
mice
humans.
We
also
review
Cushing's
classical
model
cerebrospinal
flow
present
new
framework
"third
circulation"
emphasizes
previously
unexplained
complexities
Finally,
future
directions
field,
including
emerging
theranostic
techniques
MRI
studies
required
Child s Nervous System,
Год журнала:
2024,
Номер
40(10), С. 3119 - 3127
Опубликована: Май 4, 2024
The
surgical
treatment
of
brain
tumors
has
developed
over
time,
offering
customized
strategies
for
patients
and
their
specific
lesions.
One
the
most
recent
advances
in
pediatric
neuro-oncological
surgery
is
laser
interstitial
thermal
therapy
(LITT).
However,
its
effectiveness
indications
are
still
being
evaluated.
aim
this
work
to
review
current
literature
on
LITT
low-grade
gliomas
(pLGG)
evaluate
our
initial
results
context.